scispace - formally typeset
E

Elliott M. Antman

Researcher at Brigham and Women's Hospital

Publications -  738
Citations -  187175

Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.

TL;DR: Smokers with non-ST-segment elevation acute coronary syndrome are generally younger and have fewer cardiac risk factors and there was little difference in outcomes from 30 days to 1 year for these smokers who quit versus those who did not.
Journal ArticleDOI

Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial

Michelle F. Magee, +413 more
TL;DR: There may be sex differences in response to drug therapies used to treat diabetes, hypertension, and hyperlipidemia in patients with type 2 diabetes and established coronary artery disease enrolled into the BARI 2D trial.
Journal ArticleDOI

Pacemaker-Mediated Tachycardia Initiated by Coincident P-Wave Undersensing and Ventricular Blanking Period

TL;DR: Physicians should be aware of the potential for the ventricular blanking period to participate in the initiation of pacemaker mediated tachycardias.
Journal ArticleDOI

TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction

TL;DR: The enoxaparin strategy was superior to unfractionated heparin in a majority of patients with ST-elevation myocardial infarction, except for the group at the highest risk for severe mechanical complications, in whom the 2 anticoagulant strategies showed similar results.